Vamstar estimates that nearly 525 million people currently suffer from either Type 1 or Type 2 diabetes. With Type 2 diabetes, the body either resists the effects of insulin or does not produce enough insulin to maintain normal glucose levels. Complications are similar for both Type I and Type 2 diabetes and may include cardiovascular disease, nerve damage, kidney damage, eye damage, foot conditions, hearing impairment, and Alzheimer’s disease. As such, proper glucose level monitoring is essential to avoid developing or exacerbating these chronic conditions. 

The analysis in this report is focused on the market for diabetes management which includes glucose monitoring and insulin delivery devices such as continuous glucose monitoring systems (CGM), insulin pumps, consumer glucose meters, and clinical glucose meters. It also includes insulin, anti-diabetic drugs, and traditional consumables such as needles and test strips. This report covers a global diabetes management market with details on specific equipment sales as well as associated accessories, consumables, and services. This report also features regional analysis as well as country-level analysis for key markets.